Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

NIH told regular and moderate exposure to sunlight is the key to preventing chronic disease

09.10.2003


The researcher who discovered the active form of Vitamin D, Dr. Michael F. Holick, a Professor of Medicine, Dermatology, Physiology and Biophysics at the Boston University School of Medicine, told the National Institutes of Health’s symposium on "Vitamin D and Health in the 21st Century" that the nation faces "severe Vitamin D deficiency" which, if not properly addressed, will have profound far reaching health consequences such as hundreds of thousands of new cases of breast cancer, colon cancer, heart disease, high blood pressure, diabetes, depression and multiple sclerosis.



Dr. Holick said, "We have a severe unrecognized epidemic of Vitamin D deficient patients on our hands. The public health issues at stake go far beyond bone health and involve chronic disease such as breast and colon cancer and high blood pressure. There is a mountain of well conducted, validated science that demonstrates that the production of the activated form of Vitamin D is one of the most effective ways the body controls abnormal cell growth. Regular and moderate exposure to sunlight is the best way to help the body manufacture the Vitamin D it needs. The idea that we should protect ourselves from the sun all the time is misguided and unhealthy.

"Moreover, the 1997 daily recommended allowances for Vitamin D are totally inadequate to protect public health. New science supports a significant revision of the recommendation. Adults should be getting 1000 International Units (IU) of Vitamin D a day, not the 200-600 (IU) that was recommended in 1997. Rewriting the recommended daily requirements as soon as possible should be a top priority.


"Taking diet supplements or drinking foods that have been fortified with Vitamin D is too often inadequate since a patient would have to drink the equivalent of 10 days of fortified milk or orange juice every day. Only regular and moderate exposure to sunlight fulfills the body’s needs. We ought not to be like the groundhog that is afraid to cast a shadow on a sunny day.

We need a national public health information and education campaign that encourages people to get the exposure to sunlight they need and then put on lots of sunscreen. It is not a question of a few minutes here and there. It is a question of determining how much ultraviolet light you need to maintain the right Vitamin D level in your blood and finding a way to get it.

"There is not a quick and easy answer to the question of how much is enough? African-American, Hispanics and people with a Mediterranean heritage require more. Blue-eyed, red heads from northern Europe need far less. The one basic rule that applies to everyone is avoiding sun burn. It is the burning of the skin and chronic excessive exposures, not the limited sensible exposure to ultraviolet light or sunlight, that creates the concern about skin cancer.

"The public health consequences of ignoring this epidemic are profound. Today, Vitamin D deficiency is associated with more than 100,000 additional cases of cancer and 30,000 annual cancer deaths. The epidemic extends beyond cancer to Type I diabetes, heart disease and other chronic adult disease. Possible overexposure to ultraviolet light should not be an excuse to scare people out of the sun entirely," Holick said.

Dr. Michael Holick is the former Chief of the Section of Endocrinology, Nutrition and Diabetes; Director of the General Clinical Research Center, and Professor of Medicine, Dermatology, and Physiology and Biophysics at the Boston University Medical Center. As a graduate student, Dr. Holick not only isolated and identified the active form of vitamin D but also chemically synthesized this complex molecule and was one of the first to use it for the treatment of renal osteodystrophy. After completing his Ph.D. and M.D. at the University of Wisconsin, he trained in internal medicine at the Massachusetts General Hospital.

While an intern and resident, Dr. Holick established a laboratory to evaluate how vitamin D is made in the skin, and during the past 25 years, has looked at not only the intricacies of how vitamin D is made in the skin during exposure to sunlight, but has also provided global recommendations for how sunlight exposure is important for bone health.

For the past decade at Boston University School of Medicine, he has pioneered the use of activated vitamin D compounds for the treatment of psoriasis. This is now considered to be the treatment of choice for this common skin disorder. Dr. Holick has published over 200 original scientific publications, written over 200 reviews, and edited several books including two that will be published next year.

The Indoor Tanning Association (ITA) is a national trade association representing all major manufacturers, suppliers and distributors of indoor tanning equipment as well as approximately 6,000 professional tanning facilities nationwide.

Jeff Nedelman | EurekAlert!

More articles from Health and Medicine:

nachricht Penn studies find promise for innovations in liquid biopsies
30.03.2017 | University of Pennsylvania School of Medicine

nachricht 'On-off switch' brings researchers a step closer to potential HIV vaccine
30.03.2017 | University of Nebraska-Lincoln

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

'On-off switch' brings researchers a step closer to potential HIV vaccine

30.03.2017 | Health and Medicine

Penn studies find promise for innovations in liquid biopsies

30.03.2017 | Health and Medicine

An LED-based device for imaging radiation induced skin damage

30.03.2017 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>